Tag: M.W:300-400

A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, COA of Formula: C13H9N3O6, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 19171-18-7, Name is 2-(2,6-Dioxopiperidin-3-yl)-4-nitroisoindoline-1,3-dione, molecular formula is C13H9N3O6. In a Patent, authors is £¬once mentioned of 19171-18-7

PROCESS FOR THE PREPARATION OF POMALIDOMIDE AND ITS PURIFICATION

The present invention is related to an improved process for the preparation of Pomalidomide with higher yields and high purity. Particularly the present invention relates to form A preparation of Pomalidomide and its purification. wherein the present process doesn’t involve use of dioxane solvent and avoids higher temperatures.

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 19171-18-7, help many people in the next few years.COA of Formula: C13H9N3O6

Reference£º
Piperidine – Wikipedia,
Piperidine | C5H23207N – PubChem

 

Chemistry is the experimental and theoretical study of materials on their properties at both the macroscopic and microscopic levels.In a patent£¬ Quality Control of: tert-Butyl 4-iodopiperidine-1-carboxylate, Which mentioned a new discovery about 301673-14-3

HETEROAROMATIC DERIVATIVES AS NIK INHIBITORS

The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-kappaB-inducing kinase (NIK – also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 301673-14-3, help many people in the next few years.Quality Control of: tert-Butyl 4-iodopiperidine-1-carboxylate

Reference£º
Piperidine – Wikipedia,
Piperidine | C5H23388N – PubChem

 

Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In some cases, the catalyzed mechanism may include additional steps.In a article, 159275-16-8, molcular formula is C15H21NO5S, introducing its new discovery. Quality Control of: 1-Cbz-4-(methylsulfonyloxymethyl)piperidine

CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS

Therapeutic compounds are disclosed having the general formula (I) that are useful for the treatment of metabolic disorders, including type II diabetes. The compounds have activity as agonists of GPR119. Compounds having the stereochemistry of formula (la) may also demonstrate DPP-IV inhibitory activity

One of the oldest and most widely used commercial enzyme inhibitors is aspirin, Quality Control of: 1-Cbz-4-(methylsulfonyloxymethyl)piperidine, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 159275-16-8

Reference£º
Piperidine – Wikipedia,
Piperidine | C5H23637N – PubChem

 

A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, SDS of cas: 439811-37-7, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 439811-37-7, Name is 1-Boc-4-(4-Bromobenzoyl)piperidine, molecular formula is C17H22BrNO3. In a Patent, authors is £¬once mentioned of 439811-37-7

BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF

The present invention relates to certain compounds (e.g., imidazopyrazine, imidazopyridine, imidazopyridazine and imidazpyrimidine compounds) that act as inhibitors of the MAP kinase interacting kinases MNK2a, MNK2b, MNK1a, and MNK1b. The present invention further relates to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the preparation of a medicament for the prophylaxis and treatment of diseases (e.g., proliferative diseases (e.g., cancer), inflammatory diseases, Alzheimer’s disease), as well as methods of treating these diseases

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 439811-37-7, help many people in the next few years.SDS of cas: 439811-37-7

Reference£º
Piperidine – Wikipedia,
Piperidine | C5H23814N – PubChem

 

Chemistry is the experimental and theoretical study of materials on their properties at both the macroscopic and microscopic levels.In a patent£¬ Product Details of 210962-44-0, Which mentioned a new discovery about 210962-44-0

DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS

Compounds of formula I: I are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric disorders in a patient in need are also disclosed. Such disorders include depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, addiction, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, autism, a cognitive impairment, or a neuropsychiatric symptom such as apathy, depression, anxiety, psychosis, aggression, agitation, impulse control disorders, and sleep disorders in neurological disorders such as Alzheimer’s and Parkinson’s diseases.

Because enzymes can increase reaction rates by enormous factors and tend to be very specific, Product Details of 210962-44-0, typically producing only a single product in quantitative yield, they are the focus of active research.you can also check out more blogs about 210962-44-0

Reference£º
Piperidine – Wikipedia,
Piperidine | C5H23715N – PubChem

 

Application of 265977-72-8, A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 265977-72-8, Name is (Z)-N-(1-Chloro-3-oxo-1-phenyl-3-(piperidin-1-yl)prop-1-en-2-yl)benzamide, molecular formula is C21H21ClN2O2. In a Article£¬once mentioned of 265977-72-8

Synthesis and quantitative structure-activity relationships study for phenylpropenamide derivatives as inhibitors of hepatitis B virus replication

A series of new phenylpropenamide derivatives containing different substituents was synthesized, characterized and evaluated for their anti-hepatitis B virus (HBV) activities. The quantitative structure eactivity relationships (QSAR) of phenylpropenamide compound have been studied. The 2D-QSAR models, based on DFT and multiple linear regression analysis methods, revealed that higher values of total energy (TE) and lower entropy (Stheta) enhanced the anti-HBV activities of the phenylpropenamide molecules. Predictive 3D-QSAR models were established using SYBYL multifit molecular alignment rule. The optimum models were all statistically significant with cross-validated and conventional coefficients, indicating that they were reliable enough for activity prediction.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Application of 265977-72-8, you can also check out more blogs about265977-72-8

Reference£º
Piperidine – Wikipedia,
Piperidine | C5H23842N – PubChem

 

A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, Recommanded Product: 14984-68-0, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 14984-68-0, Name is 1-(2-((4-Chlorophenyl)(phenyl)methoxy)ethyl)piperidine hydrochloride, molecular formula is C20H25Cl2NO. In a Patent, authors is £¬once mentioned of 14984-68-0

METHODS OF TREATING EPILEPSY AND RELATED NEUROLOGICAL CONDITIONS

The disclosure provides methods to prevent, inhibit or treat one or more symptoms associated with epilepsy or encephalopathies in a mammal, comprising: administering to the mammal, e.g., a composition having one of more of compounds of formula (I)-(XXXX).

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 14984-68-0, help many people in the next few years.Recommanded Product: 14984-68-0

Reference£º
Piperidine – Wikipedia,
Piperidine | C5H23799N – PubChem

 

Reference of 333954-86-2, The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.333954-86-2, Name is tert-Butyl 4-(4-cyanophenoxy)piperidine-1-carboxylate, molecular formula is C17H22N2O3. In a Patent£¬once mentioned of 333954-86-2

Anchor polymerase inhibitors (by machine translation)

The invention belongs to the field of medical technology, in particular to general formula (I) indicated by the anchor polymerase inhibitor, its pharmaceutically acceptable salt, ester, solvate or stereoisomer thereof, wherein R1 , R2 , R3 , M, n, Z, L, Q, A, X1 , X2 And Y as defined in the specification. The invention also relates to methods of preparing such compounds, pharmaceutical formulations containing these compounds and pharmaceutical composition, and this compound, its pharmaceutically acceptable salt, ester, solvate or stereoisomer thereof in preparation for treating and/or preventing the anchorage of the polymerase-mediated cancer and related diseases in the application. (by machine translation)

The reactant in an enzyme-catalyzed reaction is called a substrate. Enzyme inhibitors cause a decrease in the reaction rate of an enzyme-catalyzed reaction.I hope my blog about 333954-86-2 is helpful to your research. Reference of 333954-86-2

Reference£º
Piperidine – Wikipedia,
Piperidine | C5H23190N – PubChem

 

Chemistry is traditionally divided into organic and inorganic chemistry. Computed Properties of C18H23NO3. The former is the study of compounds containing at least one carbon-hydrogen bonds.In a patent£¬Which mentioned a new discovery about 159634-59-0

FLUOROPHENYL BICYCLIC HETEROARYL COMPOUNDS

The present invention provides a compound of formula (I); a method for manufacturing the compounds of the invention, and its use as a IGF-1R inhibitor. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Computed Properties of C18H23NO3, you can also check out more blogs about159634-59-0

Reference£º
Piperidine – Wikipedia,
Piperidine | C5H23120N – PubChem

 

Synthetic Route of 301673-14-3, The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.301673-14-3, Name is tert-Butyl 4-iodopiperidine-1-carboxylate, molecular formula is C10H18INO2. In a Patent£¬once mentioned of 301673-14-3

SUBSTITUTED QUINAZOLINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR4

The present invention relates to novel quinazolinone derivatives of formula (I) as well as pharmaceutical compositions containing these compounds. The compounds of formula (I) as provided herein can act as positive allosteric modulators of metabotropic glutamate receptor subtype 4 (mGluR4), and can thus be used as therapeutic agents, particularly in the treatment or prevention of conditions associated with altered glutamatergic signalling and/or functions or conditions which can be affected by alteration of glutamate level or signalling.

The reactant in an enzyme-catalyzed reaction is called a substrate. Enzyme inhibitors cause a decrease in the reaction rate of an enzyme-catalyzed reaction.I hope my blog about 301673-14-3 is helpful to your research. Synthetic Route of 301673-14-3

Reference£º
Piperidine – Wikipedia,
Piperidine | C5H23389N – PubChem